Literature DB >> 71484

Levamisole increases activated T lymphocytes.

M Rosenthal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 71484     DOI： 10.1016/s0140-6736(77)92538-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  The effect of levamisole on E-rosette formation by trypsinized lymphocytes.

Authors:  R Lomnitzer; A R Rabson
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330

Review 2.  Immunological reactions in heart disease.

Authors:  M Lessof
Journal:  Br Heart J       Date:  1978-03

3.  Pharmacokinetics of levamisole in healthy subjects and cancer patients.

Authors:  M Luyckx; F Rousseau; M Cazin; C Brunet; J C Cazin; J M Haguenoer; B Devulder; I Lesieur; D Lesieur; P Gosselin; L Adenis; P Cappelaere; A Demaille
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Oct-Dec       Impact factor: 2.441

4.  Rosette-increasing factor (RIF) generated in vivo following PHA skin test.

Authors:  M Kubota; H Mikawa
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

5.  Lymphocyte subsets in measles. Depressed helper/inducer subpopulation reversed by in vitro treatment with levamisole and ascorbic acid.

Authors:  M I Joffe; N R Sukha; A R Rabson
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.